Nava Health MD, LLC (NASDAQ: NAVA) Stock Competitors & Peer Comparison
See NAVA's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for NAVA and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NAVA | $0.00 | N/A | 0 | N/A | N/A | N/A |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $61.43 | +1.96% | 12.1B | 49.54 | $1.24 | N/A |
| BTSGU | $199.90 | +0.61% | 11.9B | 183.15 | $1.11 | N/A |
| TEM | $64.66 | +4.39% | 11.3B | -129.32 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $98.78 | +0.24% | 8.3B | 23.08 | $4.28 | N/A |
| TXG | $63.22 | +2.55% | 8B | -107.15 | -$0.59 | N/A |
| HNGE | $90.76 | -1.19% | 7B | 48.58 | $1.87 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
NAVA vs GEHCV Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas GEHCV's P/E ratio is N/A. In terms of profitability, NAVA's ROE is +0.15%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, NAVA is not fully comparable compared to GEHCV. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
NAVA vs BTSG Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, BTSG has a market cap of 12.1B. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while BTSG trades at $61.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas BTSG's P/E ratio is 49.54. In terms of profitability, NAVA's ROE is +0.15%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, NAVA is not fully comparable compared to BTSG. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
NAVA vs BTSGU Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, BTSGU has a market cap of 11.9B. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while BTSGU trades at $199.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas BTSGU's P/E ratio is 183.15. In terms of profitability, NAVA's ROE is +0.15%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, NAVA is not fully comparable compared to BTSGU. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check BTSGU's competition here
Tempus AI, Inc. (NASDAQ: TEM)
NAVA vs TEM Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, TEM has a market cap of 11.3B. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while TEM trades at $64.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas TEM's P/E ratio is -129.32. In terms of profitability, NAVA's ROE is +0.15%, compared to TEM's ROE of -0.55%. Regarding short-term risk, NAVA is not fully comparable compared to TEM. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
NAVA vs SGFY Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas SGFY's P/E ratio is 70.91. In terms of profitability, NAVA's ROE is +0.15%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, NAVA is not fully comparable compared to SGFY. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
NAVA vs HQY Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, HQY has a market cap of 8.3B. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while HQY trades at $98.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas HQY's P/E ratio is 23.08. In terms of profitability, NAVA's ROE is +0.15%, compared to HQY's ROE of +0.11%. Regarding short-term risk, NAVA is not fully comparable compared to HQY. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check HQY's competition here
10x Genomics, Inc. (NASDAQ: TXG)
NAVA vs TXG Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, TXG has a market cap of 8B. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while TXG trades at $63.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas TXG's P/E ratio is -107.15. In terms of profitability, NAVA's ROE is +0.15%, compared to TXG's ROE of -0.09%. Regarding short-term risk, NAVA is not fully comparable compared to TXG. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check TXG's competition here
Hinge Health, Inc. (NYSE: HNGE)
NAVA vs HNGE Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, HNGE has a market cap of 7B. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while HNGE trades at $90.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas HNGE's P/E ratio is 48.58. In terms of profitability, NAVA's ROE is +0.15%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, NAVA is not fully comparable compared to HNGE. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
NAVA vs RCM Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, RCM has a market cap of 6B. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas RCM's P/E ratio is -102.21. In terms of profitability, NAVA's ROE is +0.15%, compared to RCM's ROE of +0.00%. Regarding short-term risk, NAVA is not fully comparable compared to RCM. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check RCM's competition here
Doximity, Inc. (NYSE: DOCS)
NAVA vs DOCS Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, DOCS has a market cap of 5.1B. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while DOCS trades at $27.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas DOCS's P/E ratio is 17.71. In terms of profitability, NAVA's ROE is +0.15%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, NAVA is not fully comparable compared to DOCS. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check DOCS's competition here
Waystar Holding Corp. (NASDAQ: WAY)
NAVA vs WAY Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, WAY has a market cap of 5B. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while WAY trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas WAY's P/E ratio is 17.27. In terms of profitability, NAVA's ROE is +0.15%, compared to WAY's ROE of +0.04%. Regarding short-term risk, NAVA is not fully comparable compared to WAY. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check WAY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
NAVA vs HTFL Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, HTFL has a market cap of 4.3B. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while HTFL trades at $49.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas HTFL's P/E ratio is -24.73. In terms of profitability, NAVA's ROE is +0.15%, compared to HTFL's ROE of -0.42%. Regarding short-term risk, NAVA is not fully comparable compared to HTFL. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check HTFL's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
NAVA vs ONEM Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas ONEM's P/E ratio is -7.77. In terms of profitability, NAVA's ROE is +0.15%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, NAVA is not fully comparable compared to ONEM. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
NAVA vs PRVA Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, PRVA has a market cap of 2.6B. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while PRVA trades at $20.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas PRVA's P/E ratio is 98.43. In terms of profitability, NAVA's ROE is +0.15%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, NAVA is not fully comparable compared to PRVA. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check PRVA's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
NAVA vs NXGN Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas NXGN's P/E ratio is -266.00. In terms of profitability, NAVA's ROE is +0.15%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, NAVA is not fully comparable compared to NXGN. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check NXGN's competition here
Omnicell, Inc. (NASDAQ: OMCL)
NAVA vs OMCL Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, OMCL has a market cap of 1.6B. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while OMCL trades at $34.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas OMCL's P/E ratio is 18.23. In terms of profitability, NAVA's ROE is +0.15%, compared to OMCL's ROE of +0.03%. Regarding short-term risk, NAVA is not fully comparable compared to OMCL. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check OMCL's competition here
Agiliti, Inc. (NYSE: AGTI)
NAVA vs AGTI Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas AGTI's P/E ratio is -71.79. In terms of profitability, NAVA's ROE is +0.15%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, NAVA is not fully comparable compared to AGTI. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check AGTI's competition here
Omada Health (NASDAQ: OMDA)
NAVA vs OMDA Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, OMDA has a market cap of 1.3B. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while OMDA trades at $22.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas OMDA's P/E ratio is 318.43. In terms of profitability, NAVA's ROE is +0.15%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, NAVA is not fully comparable compared to OMDA. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check OMDA's competition here
Certara, Inc. (NASDAQ: CERT)
NAVA vs CERT Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, CERT has a market cap of 1.3B. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while CERT trades at $8.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas CERT's P/E ratio is 20.33. In terms of profitability, NAVA's ROE is +0.15%, compared to CERT's ROE of -0.07%. Regarding short-term risk, NAVA is not fully comparable compared to CERT. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check CERT's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
NAVA vs GDRX Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, GDRX has a market cap of 1.2B. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while GDRX trades at $3.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas GDRX's P/E ratio is 11.03. In terms of profitability, NAVA's ROE is +0.15%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, NAVA is not fully comparable compared to GDRX. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check GDRX's competition here
Teladoc Health, Inc. (NYSE: TDOC)
NAVA vs TDOC Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, TDOC has a market cap of 1.2B. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while TDOC trades at $6.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas TDOC's P/E ratio is -6.55. In terms of profitability, NAVA's ROE is +0.15%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, NAVA is not fully comparable compared to TDOC. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check TDOC's competition here
HealthStream, Inc. (NASDAQ: HSTM)
NAVA vs HSTM Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, HSTM has a market cap of 868.9M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while HSTM trades at $29.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas HSTM's P/E ratio is 41.31. In terms of profitability, NAVA's ROE is +0.15%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, NAVA is not fully comparable compared to HSTM. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check HSTM's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
NAVA vs CCLDO Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas CCLDO's P/E ratio is N/A. In terms of profitability, NAVA's ROE is +0.15%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, NAVA is not fully comparable compared to CCLDO. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check CCLDO's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
NAVA vs SOPH Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, SOPH has a market cap of 696.3M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while SOPH trades at $8.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas SOPH's P/E ratio is -7.48. In terms of profitability, NAVA's ROE is +0.15%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, NAVA is not fully comparable compared to SOPH. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check SOPH's competition here
Phreesia, Inc. (NYSE: PHR)
NAVA vs PHR Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, PHR has a market cap of 688M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while PHR trades at $11.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas PHR's P/E ratio is 39.75. In terms of profitability, NAVA's ROE is +0.15%, compared to PHR's ROE of +0.04%. Regarding short-term risk, NAVA is not fully comparable compared to PHR. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check PHR's competition here
Claritev Corporation (NYSE: CTEV)
NAVA vs CTEV Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, CTEV has a market cap of 664.7M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while CTEV trades at $39.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas CTEV's P/E ratio is -2.29. In terms of profitability, NAVA's ROE is +0.15%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, NAVA is not fully comparable compared to CTEV. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check CTEV's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
NAVA vs MPLN-WT Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, NAVA's ROE is +0.15%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, NAVA is not fully comparable compared to MPLN-WT. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
NAVA vs ACCD Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas ACCD's P/E ratio is -3.08. In terms of profitability, NAVA's ROE is +0.15%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, NAVA is not fully comparable compared to ACCD. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
NAVA vs SHCR Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas SHCR's P/E ratio is -3.76. In terms of profitability, NAVA's ROE is +0.15%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, NAVA is not fully comparable compared to SHCR. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check SHCR's competition here
Evolent Health, Inc. (NYSE: EVH)
NAVA vs EVH Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, EVH has a market cap of 479.7M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while EVH trades at $4.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas EVH's P/E ratio is 32.81. In terms of profitability, NAVA's ROE is +0.15%, compared to EVH's ROE of -0.99%. Regarding short-term risk, NAVA is not fully comparable compared to EVH. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check EVH's competition here
NRC Health (NASDAQ: NRC)
NAVA vs NRC Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, NRC has a market cap of 478.9M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while NRC trades at $21.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas NRC's P/E ratio is 25.91. In terms of profitability, NAVA's ROE is +0.15%, compared to NRC's ROE of +0.48%. Regarding short-term risk, NAVA is not fully comparable compared to NRC. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check NRC's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
NAVA vs SLGC Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas SLGC's P/E ratio is -3.04. In terms of profitability, NAVA's ROE is +0.15%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, NAVA is not fully comparable compared to SLGC. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
NAVA vs SLGCW Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, NAVA's ROE is +0.15%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, NAVA is not fully comparable compared to SLGCW. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
NAVA vs TBRG Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas TBRG's P/E ratio is 9.37. In terms of profitability, NAVA's ROE is +0.15%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, NAVA is not fully comparable compared to TBRG. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
NAVA vs MPLN Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas MPLN's P/E ratio is -0.23. In terms of profitability, NAVA's ROE is +0.15%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, NAVA is not fully comparable compared to MPLN. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check MPLN's competition here
So-Young International Inc. (NASDAQ: SY)
NAVA vs SY Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, SY has a market cap of 370M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while SY trades at $2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas SY's P/E ratio is -8.55. In terms of profitability, NAVA's ROE is +0.15%, compared to SY's ROE of -0.16%. Regarding short-term risk, NAVA is not fully comparable compared to SY. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check SY's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
NAVA vs TRHC Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas TRHC's P/E ratio is -4.27. In terms of profitability, NAVA's ROE is +0.15%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, NAVA is not fully comparable compared to TRHC. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
NAVA vs SMFR Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas SMFR's P/E ratio is N/A. In terms of profitability, NAVA's ROE is +0.15%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, NAVA is not fully comparable compared to SMFR. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check SMFR's competition here
American Well Corporation (NYSE: AMWL)
NAVA vs AMWL Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, AMWL has a market cap of 224.3M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while AMWL trades at $13.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas AMWL's P/E ratio is -2.98. In terms of profitability, NAVA's ROE is +0.15%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, NAVA is not fully comparable compared to AMWL. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check AMWL's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
NAVA vs SPOK Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, SPOK has a market cap of 223.1M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while SPOK trades at $10.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas SPOK's P/E ratio is 17.80. In terms of profitability, NAVA's ROE is +0.15%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, NAVA is not fully comparable compared to SPOK. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check SPOK's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
NAVA vs LFMDP Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, LFMDP has a market cap of 160.2M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while LFMDP trades at $23.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas LFMDP's P/E ratio is -724.19. In terms of profitability, NAVA's ROE is +0.15%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, NAVA is not fully comparable compared to LFMDP. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check LFMDP's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
NAVA vs OPRX Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, OPRX has a market cap of 149.2M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while OPRX trades at $7.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas OPRX's P/E ratio is 7.29. In terms of profitability, NAVA's ROE is +0.15%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, NAVA is not fully comparable compared to OPRX. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check OPRX's competition here
LifeMD, Inc. (NASDAQ: LFMD)
NAVA vs LFMD Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, LFMD has a market cap of 147.5M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while LFMD trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas LFMD's P/E ratio is -6.10. In terms of profitability, NAVA's ROE is +0.15%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, NAVA is not fully comparable compared to LFMD. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check LFMD's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
NAVA vs CPSI Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas CPSI's P/E ratio is -183.80. In terms of profitability, NAVA's ROE is +0.15%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, NAVA is not fully comparable compared to CPSI. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check CPSI's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
NAVA vs HCAT Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, HCAT has a market cap of 126.4M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while HCAT trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas HCAT's P/E ratio is 8.55. In terms of profitability, NAVA's ROE is +0.15%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, NAVA is not fully comparable compared to HCAT. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check HCAT's competition here
Augmedix, Inc. (NASDAQ: AUGX)
NAVA vs AUGX Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas AUGX's P/E ratio is -4.99. In terms of profitability, NAVA's ROE is +0.15%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, NAVA is not fully comparable compared to AUGX. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check AUGX's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
NAVA vs DH Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, DH has a market cap of 109.7M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while DH trades at $1.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas DH's P/E ratio is 4.00. In terms of profitability, NAVA's ROE is +0.15%, compared to DH's ROE of -0.79%. Regarding short-term risk, NAVA is not fully comparable compared to DH. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check DH's competition here
CareCloud, Inc. (NASDAQ: CCLD)
NAVA vs CCLD Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, CCLD has a market cap of 95.2M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while CCLD trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas CCLD's P/E ratio is 8.62. In terms of profitability, NAVA's ROE is +0.15%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, NAVA is not fully comparable compared to CCLD. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check CCLD's competition here
SCWorx Corp. (NASDAQ: WORX)
NAVA vs WORX Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, WORX has a market cap of 88M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while WORX trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas WORX's P/E ratio is -6.40. In terms of profitability, NAVA's ROE is +0.15%, compared to WORX's ROE of -0.35%. Regarding short-term risk, NAVA is not fully comparable compared to WORX. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check WORX's competition here
Forian Inc. (NASDAQ: FORA)
NAVA vs FORA Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas FORA's P/E ratio is -24.11. In terms of profitability, NAVA's ROE is +0.15%, compared to FORA's ROE of -0.17%. Regarding short-term risk, NAVA is not fully comparable compared to FORA. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
NAVA vs CCLDP Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas CCLDP's P/E ratio is N/A. In terms of profitability, NAVA's ROE is +0.15%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, NAVA is not fully comparable compared to CCLDP. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check CCLDP's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
NAVA vs SNCE Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas SNCE's P/E ratio is -0.27. In terms of profitability, NAVA's ROE is +0.15%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, NAVA is not fully comparable compared to SNCE. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
NAVA vs AKLI Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas AKLI's P/E ratio is -0.71. In terms of profitability, NAVA's ROE is +0.15%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, NAVA is not fully comparable compared to AKLI. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check AKLI's competition here
OneMedNet Corporation (NASDAQ: ONMD)
NAVA vs ONMD Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, ONMD has a market cap of 34M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while ONMD trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas ONMD's P/E ratio is -3.73. In terms of profitability, NAVA's ROE is +0.15%, compared to ONMD's ROE of +2.35%. Regarding short-term risk, NAVA is not fully comparable compared to ONMD. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check ONMD's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
NAVA vs SHLT Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas SHLT's P/E ratio is -3.87. In terms of profitability, NAVA's ROE is +0.15%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, NAVA is not fully comparable compared to SHLT. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
NAVA vs SHCRW Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, NAVA's ROE is +0.15%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, NAVA is not fully comparable compared to SHCRW. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
NAVA vs ONMDW Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, ONMDW has a market cap of 24.9M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas ONMDW's P/E ratio is N/A. In terms of profitability, NAVA's ROE is +0.15%, compared to ONMDW's ROE of +2.35%. Regarding short-term risk, NAVA is not fully comparable compared to ONMDW. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
NAVA vs STRM Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas STRM's P/E ratio is -2.40. In terms of profitability, NAVA's ROE is +0.15%, compared to STRM's ROE of -0.65%. Regarding short-term risk, NAVA is not fully comparable compared to STRM. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
NAVA vs RNLX Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas RNLX's P/E ratio is -0.33. In terms of profitability, NAVA's ROE is +0.15%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, NAVA is not fully comparable compared to RNLX. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
NAVA vs LIFW Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas LIFW's P/E ratio is -0.02. In terms of profitability, NAVA's ROE is +0.15%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, NAVA is not fully comparable compared to LIFW. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check LIFW's competition here
Babylon Holdings Limited (NYSE: BBLN)
NAVA vs BBLN Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas BBLN's P/E ratio is -0.04. In terms of profitability, NAVA's ROE is +0.15%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, NAVA is not fully comparable compared to BBLN. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check BBLN's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
NAVA vs ETAO Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas ETAO's P/E ratio is -0.01. In terms of profitability, NAVA's ROE is +0.15%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, NAVA is not fully comparable compared to ETAO. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
NAVA vs BFRG Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, BFRG has a market cap of 9.1M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while BFRG trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas BFRG's P/E ratio is -1.07. In terms of profitability, NAVA's ROE is +0.15%, compared to BFRG's ROE of -1.50%. Regarding short-term risk, NAVA is not fully comparable compared to BFRG. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check BFRG's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
NAVA vs MGRX Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, MGRX has a market cap of 6.6M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while MGRX trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas MGRX's P/E ratio is -0.29. In terms of profitability, NAVA's ROE is +0.15%, compared to MGRX's ROE of -1.06%. Regarding short-term risk, NAVA is not fully comparable compared to MGRX. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check MGRX's competition here
UpHealth, Inc. (NYSE: UPH)
NAVA vs UPH Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas UPH's P/E ratio is -0.07. In terms of profitability, NAVA's ROE is +0.15%, compared to UPH's ROE of -1.05%. Regarding short-term risk, NAVA is not fully comparable compared to UPH. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
NAVA vs UPH-WT Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, NAVA's ROE is +0.15%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, NAVA is not fully comparable compared to UPH-WT. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check UPH-WT's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
NAVA vs PEAR Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas PEAR's P/E ratio is -0.08. In terms of profitability, NAVA's ROE is +0.15%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, NAVA is not fully comparable compared to PEAR. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
NAVA vs PEARW Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas PEARW's P/E ratio is -0.00. In terms of profitability, NAVA's ROE is +0.15%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, NAVA is not fully comparable compared to PEARW. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
NAVA vs OTRK Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas OTRK's P/E ratio is -0.02. In terms of profitability, NAVA's ROE is +0.15%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, NAVA is not fully comparable compared to OTRK. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check OTRK's competition here
CareMax, Inc. (NASDAQ: CMAX)
NAVA vs CMAX Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas CMAX's P/E ratio is -0.00. In terms of profitability, NAVA's ROE is +0.15%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, NAVA is not fully comparable compared to CMAX. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check CMAX's competition here
Bullfrog AI Holdings, Inc. Warrants (NASDAQ: BFRGW)
NAVA vs BFRGW Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, BFRGW has a market cap of 1.4M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while BFRGW trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas BFRGW's P/E ratio is -0.92. In terms of profitability, NAVA's ROE is +0.15%, compared to BFRGW's ROE of -1.50%. Regarding short-term risk, NAVA is not fully comparable compared to BFRGW. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check BFRGW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
NAVA vs LIFWZ Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, NAVA's ROE is +0.15%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, NAVA is not fully comparable compared to LIFWZ. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check LIFWZ's competition here
Aclarion, Inc. (NASDAQ: ACON)
NAVA vs ACON Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, ACON has a market cap of 1.2M. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while ACON trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas ACON's P/E ratio is -0.25. In terms of profitability, NAVA's ROE is +0.15%, compared to ACON's ROE of -0.59%. Regarding short-term risk, NAVA is not fully comparable compared to ACON. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check ACON's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
NAVA vs HCTI Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, HCTI has a market cap of 990.8K. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while HCTI trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas HCTI's P/E ratio is -0.11. In terms of profitability, NAVA's ROE is +0.15%, compared to HCTI's ROE of -0.56%. Regarding short-term risk, NAVA is not fully comparable compared to HCTI. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check HCTI's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
NAVA vs VSEEW Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, VSEEW has a market cap of 560.3K. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, NAVA's ROE is +0.15%, compared to VSEEW's ROE of -4.01%. Regarding short-term risk, NAVA is not fully comparable compared to VSEEW. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
NAVA vs MSPRZ Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, NAVA's ROE is +0.15%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, NAVA is not fully comparable compared to MSPRZ. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check MSPRZ's competition here
VSee Health, Inc. (NASDAQ: VSEE)
NAVA vs VSEE Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, VSEE has a market cap of 249.7K. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while VSEE trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas VSEE's P/E ratio is -0.03. In terms of profitability, NAVA's ROE is +0.15%, compared to VSEE's ROE of -4.01%. Regarding short-term risk, NAVA is not fully comparable compared to VSEE. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check VSEE's competition here
Akerna Corp. (NASDAQ: KERN)
NAVA vs KERN Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas KERN's P/E ratio is -0.01. In terms of profitability, NAVA's ROE is +0.15%, compared to KERN's ROE of -0.20%. Regarding short-term risk, NAVA is not fully comparable compared to KERN. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
NAVA vs KERNW Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas KERNW's P/E ratio is -0.00. In terms of profitability, NAVA's ROE is +0.15%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, NAVA is not fully comparable compared to KERNW. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
NAVA vs LIFWW Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas LIFWW's P/E ratio is N/A. In terms of profitability, NAVA's ROE is +0.15%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, NAVA is not fully comparable compared to LIFWW. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
NAVA vs CMAXW Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas CMAXW's P/E ratio is N/A. In terms of profitability, NAVA's ROE is +0.15%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, NAVA is not fully comparable compared to CMAXW. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check CMAXW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
NAVA vs ZCMD Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, ZCMD has a market cap of 30.7K. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while ZCMD trades at $0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, NAVA's ROE is +0.15%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, NAVA is not fully comparable compared to ZCMD. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check ZCMD's competition here
Aclarion, Inc. (NASDAQ: ACONW)
NAVA vs ACONW Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, ACONW has a market cap of 13.8K. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas ACONW's P/E ratio is N/A. In terms of profitability, NAVA's ROE is +0.15%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, NAVA is not fully comparable compared to ACONW. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check ACONW's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
NAVA vs IMS Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, IMS has a market cap of 0. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas IMS's P/E ratio is N/A. In terms of profitability, NAVA's ROE is +0.15%, compared to IMS's ROE of +0.27%. Regarding short-term risk, NAVA is not fully comparable compared to IMS. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check IMS's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
NAVA vs SMFRW Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas SMFRW's P/E ratio is N/A. In terms of profitability, NAVA's ROE is +0.15%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, NAVA is not fully comparable compared to SMFRW. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check SMFRW's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
NAVA vs AFFX Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, AFFX has a market cap of 0. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas AFFX's P/E ratio is N/A. In terms of profitability, NAVA's ROE is +0.15%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, NAVA is not fully comparable compared to AFFX. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check AFFX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
NAVA vs MSPRV Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas MSPRV's P/E ratio is N/A. In terms of profitability, NAVA's ROE is +0.15%, compared to MSPRV's ROE of N/A. Regarding short-term risk, NAVA is not fully comparable compared to MSPRV. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check MSPRV's competition here
CareCloud, Inc. (NASDAQ: MTBC)
NAVA vs MTBC Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, MTBC has a market cap of 0. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas MTBC's P/E ratio is N/A. In terms of profitability, NAVA's ROE is +0.15%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, NAVA is not fully comparable compared to MTBC. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check MTBC's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
NAVA vs MTBCP Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas MTBCP's P/E ratio is N/A. In terms of profitability, NAVA's ROE is +0.15%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, NAVA is not fully comparable compared to MTBCP. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
NAVA vs MTBCO Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas MTBCO's P/E ratio is N/A. In terms of profitability, NAVA's ROE is +0.15%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, NAVA is not fully comparable compared to MTBCO. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check MTBCO's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
NAVA vs CNVY Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, CNVY has a market cap of 0. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas CNVY's P/E ratio is -71.50. In terms of profitability, NAVA's ROE is +0.15%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, NAVA is not fully comparable compared to CNVY. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check CNVY's competition here
NantHealth, Inc. (NASDAQ: NH)
NAVA vs NH Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, NH has a market cap of 0. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas NH's P/E ratio is -0.12. In terms of profitability, NAVA's ROE is +0.15%, compared to NH's ROE of +0.35%. Regarding short-term risk, NAVA is not fully comparable compared to NH. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check NH's competition here
Cerner Corporation (NASDAQ: CERN)
NAVA vs CERN Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, CERN has a market cap of 0. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas CERN's P/E ratio is 55.84. In terms of profitability, NAVA's ROE is +0.15%, compared to CERN's ROE of +0.14%. Regarding short-term risk, NAVA is not fully comparable compared to CERN. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check CERN's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
NAVA vs KURIU Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, KURIU has a market cap of 0. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas KURIU's P/E ratio is N/A. In terms of profitability, NAVA's ROE is +0.15%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, NAVA is not fully comparable compared to KURIU. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check KURIU's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
NAVA vs CHNGU Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas CHNGU's P/E ratio is N/A. In terms of profitability, NAVA's ROE is +0.15%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, NAVA is not fully comparable compared to CHNGU. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check CHNGU's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
NAVA vs CHNG Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, CHNG has a market cap of 0. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas CHNG's P/E ratio is -152.72. In terms of profitability, NAVA's ROE is +0.15%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, NAVA is not fully comparable compared to CHNG. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check CHNG's competition here
Castlight Health, Inc. (NYSE: CSLT)
NAVA vs CSLT Comparison September 2026
Nava Health MD, LLC (NASDAQ: NAVA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAVA stands at 0. In comparison, CSLT has a market cap of 0. Regarding current trading prices, NAVA is priced at $0.00 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAVA currently has a P/E ratio of N/A, whereas CSLT's P/E ratio is -37.27. In terms of profitability, NAVA's ROE is +0.15%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, NAVA is not fully comparable compared to CSLT. This indicates unavailable risk data in terms of short-term price fluctuations for NAVA.Check CSLT's competition here